The Mettl3 epitranscriptomic writer amplifies p53 stress responses.
DNA damage
METTL14
METTL3
N(6)-methyladenosine (m6A) modification
epitranscriptomics
lung cancer
mass spectrometry
methyltransferase complex
p53
tumor suppressor
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
07 07 2022
07 07 2022
Historique:
received:
23
03
2021
revised:
05
01
2022
accepted:
06
04
2022
pubmed:
6
5
2022
medline:
14
7
2022
entrez:
5
5
2022
Statut:
ppublish
Résumé
The p53 transcription factor drives anti-proliferative gene expression programs in response to diverse stressors, including DNA damage and oncogenic signaling. Here, we seek to uncover new mechanisms through which p53 regulates gene expression using tandem affinity purification/mass spectrometry to identify p53-interacting proteins. This approach identified METTL3, an m
Identifiants
pubmed: 35512709
pii: S1097-2765(22)00321-5
doi: 10.1016/j.molcel.2022.04.010
pmc: PMC9807187
mid: NIHMS1860204
pii:
doi:
Substances chimiques
Transcription Factors
0
Tumor Suppressor Protein p53
0
RNA
63231-63-0
Methyltransferases
EC 2.1.1.-
Mettl3 protein, mouse
EC 2.1.1.-
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
2370-2384.e10Subventions
Organisme : NCI NIH HHS
ID : R01 CA234605
Pays : United States
Organisme : NCI NIH HHS
ID : DP1 CA238296
Pays : United States
Organisme : Howard Hughes Medical Institute
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA127724
Pays : United States
Organisme : NICHD NIH HHS
ID : R01 HD086634
Pays : United States
Organisme : NCI NIH HHS
ID : R35 CA197591
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA095441
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA250534
Pays : United States
Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests H.Y.C. is a co-founder of Accent Therapeutics, Boundless Bio, and an advisor of 10x Genomics, Arsenal Biosciences, and Spring Discovery. H.Y.C. is an advisory board member of Molecular Cell. C.C. is an advisor and equity holder of GRAIL/Illumina, Ravel Biotechnology, and DeepCell, and an advisor to NanoString and Genentech. The remaining authors declare no competing interests.
Références
Oncotarget. 2014 Feb 28;5(4):933-43
pubmed: 24659749
Nat Med. 2017 Nov;23(11):1369-1376
pubmed: 28920958
Nature. 2009 Aug 27;460(7259):1085-6
pubmed: 19713919
Genes Dev. 2013 May 1;27(9):1016-31
pubmed: 23651856
Nucleic Acids Res. 2019 Jan 8;47(D1):D766-D773
pubmed: 30357393
Cold Spring Harb Perspect Med. 2017 Jan 3;7(1):
pubmed: 27864306
Nat Rev Mol Cell Biol. 2018 Oct;19(10):621-637
pubmed: 29946135
Cell Death Differ. 2018 Jan;25(1):93-103
pubmed: 29099489
Nat Methods. 2011 Nov 20;9(1):72-4
pubmed: 22101854
Nat Methods. 2007 Mar;4(3):207-14
pubmed: 17327847
Nat Neurosci. 2018 Feb;21(2):195-206
pubmed: 29335608
Cell Syst. 2018 Mar 28;6(3):271-281.e7
pubmed: 29596782
Cancer Cell. 2020 Mar 16;37(3):270-288
pubmed: 32183948
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Proc Natl Acad Sci U S A. 2021 Aug 31;118(35):
pubmed: 34452996
Nucleic Acids Res. 2016 Jan 4;44(D1):D81-9
pubmed: 26612867
J Proteome Res. 2006 Sep;5(9):2339-47
pubmed: 16944946
Nat Methods. 2017 Jul;14(7):737-742
pubmed: 28530655
Nat Neurosci. 2010 Jan;13(1):133-40
pubmed: 20023653
Genome Biol. 2016 Dec 16;17(1):261
pubmed: 27986087
BMC Bioinformatics. 2013 Apr 15;14:128
pubmed: 23586463
Nat Methods. 2016 Jun;13(6):508-14
pubmed: 27018577
Nat Cell Biol. 2018 Sep;20(9):1074-1083
pubmed: 30154548
Mol Cell. 2019 May 16;74(4):640-650
pubmed: 31100245
Nature. 2017 Dec 7;552(7683):126-131
pubmed: 29186125
Cell. 2015 Jun 4;161(6):1388-99
pubmed: 26046440
Nature. 2021 May;593(7860):597-601
pubmed: 33902106
Nat Struct Mol Biol. 2013 Dec;20(12):1434-42
pubmed: 24213538
Genome Biol. 2014;15(12):550
pubmed: 25516281
Mol Cell. 2020 Nov 5;80(3):452-469.e9
pubmed: 33157015
Nat Commun. 2016 Aug 25;7:12626
pubmed: 27558897
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cell. 1992 Jun 26;69(7):1237-45
pubmed: 1535557
Bioinformatics. 2018 Sep 1;34(17):i884-i890
pubmed: 30423086
Genes Dev. 2017 Jun 1;31(11):1095-1108
pubmed: 28698299
Nat Rev Mol Cell Biol. 2019 Oct;20(10):608-624
pubmed: 31520073
Sci Transl Med. 2018 Apr 11;10(436):
pubmed: 29643228
Mol Cell. 2016 Feb 18;61(4):507-519
pubmed: 26876937
Cell. 2009 May 1;137(3):413-31
pubmed: 19410540
J Cell Biol. 2020 Nov 2;219(11):
pubmed: 32886745
Nature. 2018 Mar 8;555(7695):256-259
pubmed: 29489750
Nat Protoc. 2009;4(7):1064-72
pubmed: 19561589
J Mol Evol. 2002 Oct;55(4):431-44
pubmed: 12355263
Bioinformatics. 2016 Apr 1;32(7):1097-9
pubmed: 26607490
Dev Cell. 2021 Jul 26;56(14):2089-2102.e11
pubmed: 34242585
Cell. 2017 Sep 7;170(6):1062-1078
pubmed: 28886379
Cell. 2015 Nov 5;163(4):999-1010
pubmed: 26593424
Nature. 1993 Apr 29;362(6423):857-60
pubmed: 8479525
Mol Cell. 2008 May 9;30(3):303-14
pubmed: 18471976
Nat Struct Mol Biol. 2017 Jul;24(7):561-569
pubmed: 28581511
Proc Natl Acad Sci U S A. 2017 May 2;114(18):E3642-E3651
pubmed: 28416666
RNA. 2007 Nov;13(11):1825-33
pubmed: 17804642
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Nature. 1997 May 15;387(6630):299-303
pubmed: 9153396
Oncogene. 2004 May 27;23(25):4371-9
pubmed: 15064727
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell Res. 2017 Mar;27(3):315-328
pubmed: 28106072
Cell Stem Cell. 2014 Dec 4;15(6):707-19
pubmed: 25456834
Nature. 2017 Mar 23;543(7646):573-576
pubmed: 28297716
Cold Spring Harb Perspect Biol. 2010 Jan;2(1):a001008
pubmed: 20182602
Nat Rev Genet. 2018 Jun;19(6):385-397
pubmed: 29556092
Nat Methods. 2008 Jul;5(7):621-8
pubmed: 18516045
Nat Cell Biol. 2018 Mar;20(3):285-295
pubmed: 29476152
Nat Genet. 2005 Feb;37(2):145-52
pubmed: 15654339
Genome Res. 2017 Mar;27(3):491-499
pubmed: 28100584
Mol Cell. 2003 Oct;12(4):1015-27
pubmed: 14580351
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nature. 2013 Oct 17;502(7471):333-339
pubmed: 24132290
Nat Cell Biol. 2019 Jun;21(6):700-709
pubmed: 31061465
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Genes Dev. 2001 Dec 15;15(24):3243-8
pubmed: 11751630
Oncotarget. 2017 Oct 10;8(56):96103-96116
pubmed: 29221190
Cell Stem Cell. 2018 Feb 1;22(2):191-205.e9
pubmed: 29290617
Nucleic Acids Res. 2015 Jan;43(Database issue):D30-5
pubmed: 25414350
Nat Rev Clin Oncol. 2018 Jan;15(1):13-30
pubmed: 28948977
Cell. 2011 May 13;145(4):571-83
pubmed: 21565614
Nat Rev Cancer. 2014 May;14(5):359-70
pubmed: 24739573
Cell Rep. 2017 Mar 14;18(11):2622-2634
pubmed: 28297667
Nature. 2019 Mar;567(7748):414-419
pubmed: 30867593
Oncogene. 2017 Feb 2;36(5):723-730
pubmed: 27375027
Nature. 1997 May 15;387(6630):296-9
pubmed: 9153395
Nature. 2018 Sep;561(7724):556-560
pubmed: 30232453
Mol Cell. 2016 May 5;62(3):335-345
pubmed: 27117702
Nature. 2014 Jan 2;505(7481):117-20
pubmed: 24284625
Proc Natl Acad Sci U S A. 2011 Oct 11;108(41):17123-8
pubmed: 21969549
Cancer Cell. 2017 Oct 9;32(4):460-473.e6
pubmed: 29017057
Genes Dev. 2015 Jul 15;29(14):1576-85
pubmed: 26178787